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Nursing personnel are critical to the delivery of quality patient care in hospitals and spend substantial time at the bedside. As such, RNs and nursing assistants (NAs) are at the forefront of patient-clinician communication. Their unique perceptions are important for understanding strengths and weaknesses of hospital systems, how they fail, and how to fix them. 1 Therefore, nursing administrators should rely on the feedback and perspectives of RNs and NAs when making decisions regarding communication resources that enhance patientclinician communication.
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